Skip to Content
 
 
 
 

NRG-GI004: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or Without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer (Location: Aberdeen)

Objective

Clinical Trial Details >>

Principal Investigator(s)
Benjamin Solomon, MD

Clinical Trial Categories

  • Colorectal Cancer
Contact
Medical Oncology Research Coordinators at 605-322-3295
or medoncresearch@avera.org

Location

  • Avera Cancer Institute at Aberdeen
    310 S Penn St. Suite 105
    Aberdeen, SD 57401
    Main: 605-622-8700
    Fax: 605-622-5056

Moving Health Forward

Avera is a health ministry rooted in the Gospel. Our mission is to make a positive impact in the lives and health of persons and communities by providing quality services guided by Christian values.

© 2022 Avera Health, Sioux Falls, SD. All Rights Reserved.